2023
|
Development of a Companion Diagnostic Assay for Detection of ADAM8-Positive Cancers
|
5R44CA275462-02
|
|
2019
|
Development of a Companion Diagnostic Assay for Detection of ADAM8-Positive Cancers
|
1R43CA239942-01
|
|
2019
|
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
|
3R44CA200161-03S1
|
|
2019
|
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
|
5R44CA200161-03
|
|
2018
|
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
|
2R44CA200161-02A1
|
|
2018
|
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
|
3R41CA200161-01A1S3
|
|
2017
|
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
|
3R41CA200161-01A1S2
|
|
2017
|
ADAM8 Is a Novel Target for Treatment of Triple-Negative Breast Cancer
|
5R21CA194955-02
|
|
2016
|
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
|
3R41CA200161-01A1S1
|
|
2016
|
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
|
1R41CA200161-01A1
|
|
2016
|
ADAM8 Is a Novel Target for Treatment of Triple-Negative Breast Cancer
|
1R21CA194955-01A1
|
|
2014
|
Lysyl Oxidase Propeptide: Breast Cancer Inhibitor
|
5R01CA143108-05
|
12
|
2013
|
Lysyl Oxidase Propeptide: Breast Cancer Inhibitor
|
5R01CA143108-04
|
12
|
2012
|
Lysyl Oxidase Propeptide: Breast Cancer Inhibitor
|
5R01CA143108-03
|
12
|
2012
|
Roles of NF-kB/Rel in the pathogenesis of breast cancer
|
5R01CA129129-05
|
10
|
2012
|
Signaling Pathways in Stages of Tumorigenesis
|
5P01ES011624-11
|
66
|
2012
|
CORE A: Administrative Core
|
5P01ES011624-11-9003
|
66
|
2012
|
Research Project 3: Role of the NF-kB/Rel in Mammary Carcinogenesis
|
5P01ES011624-11-3
|
66
|
2011
|
Lysyl Oxidase Propeptide: Breast Cancer Inhibitor
|
5R01CA143108-02
|
12
|
2011
|
Roles of NF-kB/Rel in the pathogenesis of breast cancer
|
5R01CA129129-04
|
10
|
2011
|
Signaling Pathways in Stages of Tumorigenesis
|
5P01ES011624-10
|
66
|
2011
|
Research Project 3: Role of the NF-kB/Rel in Mammary Carcinogenesis
|
5P01ES011624-10-3
|
66
|
2011
|
CORE A: Administrative Core
|
5P01ES011624-10-9003
|
66
|
2010
|
Research Project 3: Role of the NF-kB/Rel in Mammary Carcinogenesis
|
5P01ES011624-09-3
|
66
|
2010
|
CORE A: Administrative Core
|
5P01ES011624-09-9003
|
66
|
2010
|
Lysyl Oxidase Propeptide: Breast Cancer Inhibitor
|
1R01CA143108-01
|
12
|
2010
|
Roles of NF-kB/Rel in the pathogenesis of breast cancer
|
7R01CA129129-03
|
10
|
2010
|
Signaling Pathways in Stages of Tumorigenesis
|
5P01ES011624-09
|
66
|
2009
|
Roles of NF-kB/Rel in the pathogenesis of breast cancer
|
5R01CA129129-02
|
10
|
2009
|
Signaling Pathways in Stages of Tumorigenesis
|
7P01ES011624-08
|
66
|
2009
|
Signaling Pathways in Stages of Tumorigenesis
|
5P01ES011624-07
|
66
|
2009
|
CORE A: Administrative Core
|
7P01ES011624-08-9003
|
66
|
2009
|
Research Project 3: Role of the NF-kB/Rel in Mammary Carcinogenesis
|
7P01ES011624-08-3
|
66
|
2009
|
CORE A: Administrative Core
|
5P01ES011624-07-9003
|
66
|
2009
|
Research Project 3: Role of the NF-kB/Rel in Mammary Carcinogenesis
|
5P01ES011624-07-3
|
66
|
2008
|
CORE A: Administrative Core
|
2P01ES011624-06A1-9003
|
66
|
2008
|
Research Project 3: Role of the NF-kB/Rel in Mammary Carcinogenesis
|
2P01ES011624-06A1-3
|
66
|
2008
|
Roles of NF-kB/Rel in the pathogenesis of breast cancer
|
1R01CA129129-01A1
|
10
|
2008
|
Signaling Pathways in Stages of Tumorigenesis
|
2P01ES011624-06A1
|
66
|
2008
|
LYSYL OXIDASE INHIBITION OF RAS-MEDIATED TRANSFORMATION
|
5R01CA082742-10
|
28
|
2007
|
LYSYL OXIDASE INHIBITION OF RAS-MEDIATED TRANSFORMATION
|
5R01CA082742-09
|
28
|
2007
|
C-MYC EXPRESSION AND APOPTOSIS IN B CELLS
|
5R01CA036355-22
|
56
|
2006
|
LYSYL OXIDASE INHIBITION OF RAS-MEDIATED TRANSFORMATION
|
5R01CA082742-08
|
28
|
2006
|
C-MYC EXPRESSION AND APOPTOSIS IN B CELLS
|
5R01CA036355-21
|
56
|
2005
|
Signaling Pathways in Stage of Mammary Tumorigenesis
|
5P01ES011624-05
|
66
|
2005
|
LYSYL OXIDASE INHIBITION OF RAS-MEDIATED TRANSFORMATION
|
5R01CA082742-07
|
28
|
2005
|
C-MYC EXPRESSION AND APOPTOSIS IN B CELLS
|
5R01CA036355-20
|
56
|
2004
|
Signaling Pathways in Stage of Mammary Tumorigenesis
|
5P01ES011624-04
|
66
|
2004
|
LYSYL OXIDASE INHIBITION OF RAS-MEDIATED TRANSFORMATION
|
2R01CA082742-06
|
28
|
2004
|
C-MYC EXPRESSION AND APOPTOSIS IN B CELLS
|
5R01CA036355-19
|
56
|
2003
|
Coordinated Control of Vascular SMC Growth &Fibrogeneni
|
2P01HL013262-30A1-34
|
164
|
2003
|
Signaling Pathways in Stage of Mammary Tumorigenesis
|
5P01ES011624-03
|
66
|
2003
|
NFKB/REL AND THE PATHOGENESIS OF BREAST CANCER
|
5R01CA082742-05
|
28
|
2003
|
C-MYC EXPRESSION AND APOPTOSIS IN B CELLS
|
2R01CA036355-18A1
|
56
|
2002
|
ROLE OF NFKB/REL IN MAMMARY CARCINOGENESIS
|
5P01ES011624-02-3
|
66
|
2002
|
B-MYB REGULATION OF MATRIX GENE EXPRESSION
|
5P01HL013262-29-34
|
164
|
2002
|
Signaling Pathways in Stage of Mammary Tumorigenesis
|
5P01ES011624-02
|
66
|
2002
|
C-MYC EXPRESSION AND APOPTOSIS IN A B CELL LINE
|
3R01CA036355-17S1
|
56
|
2001
|
Signaling Pathways in Stage of Mammary Tumorigenesis
|
1P01ES011624-01
|
66
|
2001
|
ROLE OF NFKB/REL IN MAMMARY CARCINOGENESIS
|
1P01ES011624-01-3
|
66
|
2001
|
B-MYB REGULATION OF MATRIX GENE EXPRESSION
|
5P01HL013262-28-34
|
164
|
2001
|
NFKB/REL AND THE PATHOGENESIS OF BREAST CANCER
|
5R01CA082742-03
|
28
|
2001
|
NFKB/REL AND THE PATHOGENESIS OF BREAST CANCER
|
3R01CA082742-03S1
|
28
|
2001
|
C-MYC EXPRESSION AND APOPTOSIS IN A B CELL LINE
|
5R01CA036355-17
|
56
|
2000
|
B-MYB REGULATION OF MATRIX GENE EXPRESSION
|
5P01HL013262-27-34
|
164
|
2000
|
NFKB/REL AND THE PATHOGENESIS OF BREAST CANCER
|
5R01CA082742-02
|
28
|
2000
|
C-MYC EXPRESSION AND APOPTOSIS IN A B CELL LINE
|
5R01CA036355-16
|
56
|
1999
|
NFKB/REL AND THE PATHOGENESIS OF BREAST CANCER
|
1R01CA082742-01
|
28
|
1999
|
B-MYB REGULATION OF MATRIX GENE EXPRESSION
|
5P01HL013262-26-34
|
164
|
1999
|
C-MYC EXPRESSION AND APOPTOSIS IN A B CELL LINE
|
5R01CA036355-15
|
56
|
1998
|
B-MYB REGULATION OF MATRIX GENE EXPRESSION
|
2P01HL013262-25A1-34
|
164
|
1998
|
C-MYC EXPRESSION AND APOPTOSIS IN A B CELL LINE
|
5R01CA036355-14
|
56
|
1997
|
REGULATION OF MATRIX GENE EXPRESSION BY B-MYB
|
1R01HL057326-01A1
|
2
|
1997
|
C-MYC EXPRESSION AND APOPTOSIS IN A B CELL LINE
|
2R01CA036355-13
|
56
|
1996
|
C-MYC EXPRESSION AND APOPTOSIS IN A B CELL LINE
|
5R01CA036355-12
|
56
|
1995
|
C-MYC EXPRESSION AND APOPTOSIS IN A B CELL LINE
|
5R01CA036355-11
|
56
|
1994
|
C-MYC EXPRESSION AND APOPTOSIS IN A B CELL LINE
|
5R01CA036355-10
|
56
|
1993
|
C-MYC EXPRESSION AND APOPTOSIS IN A B CELL LINE
|
2R01CA036355-09A2
|
56
|
1991
|
EXPRESSION OF ONCOGENES &IGA GENES IN TRANSFORMED CELLS
|
5R01CA036355-08
|
56
|
1990
|
EXPRESSION OF ONCOGENES &IGA GENES IN TRANSFORMED CELLS
|
5R01CA036355-07
|
56
|
1989
|
EXPRESSION OF ONCOGENES &IGA GENES IN TRANSFORMED CELLS
|
5R01CA036355-06
|
56
|
1988
|
EXPRESSION OF ONCOGENES &IGA GENES IN TRANSFORMED CELLS
|
5R01CA036355-05
|
56
|
1987
|
ESTROGEN REGULATION OF AORTIC MUSCLE COLLAGEN EXPRESSION
|
5R01HL035003-03
|
1
|
1987
|
EXPRESSION OF ONCOGENES &IGA GENES IN TRANSFORMED CELLS
|
2R01CA036355-04
|
56
|
1986
|
ESTROGEN REGULATION OF AORTIC MUSCLE COLLAGEN EXPRESSION
|
5R01HL035003-02
|
1
|
1986
|
EXPRESSION OF ONCOGENES &IGA GENES IN TRANSFORMED CELLS
|
5R01CA036355-03
|
56
|
1985
|
ESTROGEN REGULATION OF AORTIC MUSCLE COLLAGEN EXPRESSION
|
1R01HL035003-01
|
1
|
1985
|
EXPRESSION OF ONCOGENES &IGA GENES IN TRANSFORMED CELLS
|
5R01CA036355-02
|
56
|